Analyst Reco. Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Real-time Estimate Cboe BZX Other stock markets 12:11:16 2024-04-29 EDT			5-day change	1st Jan Change
9.02 ^USD	-0.22%		-0.17%	-3.06%

03-06	Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	MT
02-21	Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	03-06	MT
Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	02-21	MT
Mizuho Trims Price Target on Pediatrix Medical to $9 From $10, Maintains Neutral Rating	02-21	MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $10 From $10.50, Keeps Hold Rating	02-21	MT
UBS Initiates Coverage on Pediatrix Medical Group With Neutral Rating, $9.50 Price Target	11-30	MT
Deutsche Bank Cuts Pediatrix Medical Price Target to $9 From $14, Maintains Sell Rating	11-03	MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $15 From $17, Maintains Hold Rating	23-05-09	MT
Deutsche Bank Adjusts Pediatrix Medical Price Target to $14 From $15.50, Maintains Sell Rating	23-05-03	MT
Credit Suisse Adjusts Price Target on Pediatrix Medical to $23 From $27, Maintains Outperform Rating	23-02-22	MT
Credit Suisse Adjusts Pediatrix Medical Group's Price Target to $27 From $28, Keeps Outperform Rating	22-12-05	MT
Mizuho Adjusts Price Target on Pediatrix Medical to $17 From $21, Maintains Neutral Rating	22-11-16	MT
SVB Leerink Adjusts Price Target on Pediatrix Medical to $16 From $20, Maintains Market Perform Rating	22-11-04	MT
Deutsche Bank Adjusts Pediatrix Medical Group Price Target to $14 From $16, Maintains Sell Rating	22-11-04	MT
Credit Suisse Lowers Pediatrix Medical Group's Price Target to $28 from $30 After Lower-than-Expected Q2 EBITDA, Keeps Outperform Rating	22-08-11	MT
BMO Capital Lowers Pediatrix Medical Group's Price Target to $23 From $25, Maintains Market Perform Rating	22-08-10	MT
S&P Raises Pediatrix Medical Group Rating To 'BB-' On Better Leverage, Stable Growth; Outlook Stable	22-07-12	MT
SVB Securities Adjusts Mednax's Price Target to $20 from $24, Keeps Market Perform Rating	22-05-12	MT
Deutsche Bank Adjusts Price Target on Mednax to $16 From $24, Maintains Sell Rating	22-05-10	MT
Credit Suisse Trims Mednax's PT to $30 from $31, Lowers 2022, 2023 Estimates as Q1 Underperformed Consensus on Ex-Pro Forma Basis; Maintains Outperform Rating	22-05-03	MT
Mizuho Adjusts Mednax's Price Target to $23 from $28, Keeps Neutral Rating	22-05-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Analyst Reco.

Filters